ReNerve advances nerve guide matrix to stage 3
ReNerve (ASX:RNV) has advanced its NervAlign Nerve Guide Matrix to Stage 3 commercial production.
Grafa News and Videos — Page 1088
Nagambie Resources slashes debt by $9M
Nagambie Resources (ASX:NAG) announced a $9 million reduction in total debt, marking a shift in the company’s financial structure.
Health
Xenitra acquires Fukang to expand Asian OTC business
Xenitra (ASX:XEN) announced the 100% acquisition of Hong Kong Fukang Trading.
-640x360.webp&w=3840&q=75)
QEM acquires US critical mineral projects in Idaho
QEM (ASX:QEM) announced the strategic acquisition of past-producing fluorspar, tungsten, and niobium projects in Idaho.
OD6 Metals hits ultra-high-grade fluorspar in Nevada
OD6 Metals (ASX:OD6) reported ultra-high-grade channel sampling results from the Horseshoe prospect at its Quinn Fluorspar Project.
Health
PYC Therapeutics advances blinding eye disease drug trials
PYC Therapeutics (ASX:PYC) advances its PYC-001 drug candidate to multiple-dose testing for blinding eye disease ADOA.
Omnia Metals expands into US critical minerals sector
Omnia Metals (ASX:OM1) announced a multi-faceted strategic expansion into the United States' critical minerals sector.
Ovanti secures $5.3M for global Super App
Ovanti (ASX:OVT) raised $5.3 million to scale its global BNPL platform and AI-driven "Super App" strategy.
Rinehart ordered to pay royalties to rival dynasties
A Supreme Court justice has ordered Gina Rinehart’s Hancock Prospecting to pay royalties to two rival dynasties.
FDA grants Orphan Drug status to Immutep's sarcoma therapy
FDA granted Immutep (ASX:IMM) Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma.
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas